Venture Life Group 6/30/2025 Earnings Report

Venture Life Group EPS Results

• Actual EPS: GBX 3.96
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: N/A

Venture Life Group Revenue Results

• Actual Revenue: N/A
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

Venture Life Group Announcement Details

• Date: 6/30/2025
• Time: N/A
• Conference Call Date: N/A
• Conference Call Time: N/A

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market. With operations in the UK, The Netherlands and Italy, the Group's product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women's intimate healthcare, fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing. The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples. In the UK and The Netherlands these are supplied direct by the company to retailers, elsewhere they are supplied by the Group's international distribution partners. Through its Development & Manufacturing facilities in Italy & Sweden the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.